share_log

Aprea Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Oct 11, 2022 17:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more